Voyageur Pharmaceuticals (TSE:VM) has released an update.
Voyageur Pharmaceuticals Ltd. has announced the issuance of 435,925 Deferred Share Units to its directors as part of its equity incentive plan, aiming to align the interests of directors with those of shareholders. The company, which is developing cost-effective medical imaging solutions, also emphasizes its commitment to environmental sustainability through the adoption of carbon-capture technology and its vertically integrated business model for radiology contrast media drugs.
For further insights into TSE:VM stock, check out TipRanks’ Stock Analysis page.
